The rich research portfolio of the Monell Chemical Senses Center on sweet taste goes way back: Monell scientists were one of ...

Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of incretin mimetic medicines for the treatment of Type 2 ...

(RTTNews) - Gilead Sciences Inc. (GILD) announced interim results from the ongoing ASSURE study demonstrating treatment with seladelpar, an investigational PPAR delta agonist, led to improvements in ...

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced positive results from the Phase Ib ...

One in eight adults (12 percent) say they have ever taken a glucagon-like peptide-1 receptor agonist (GLP-1 RA) and 6 percent ...

South San Francisco, California Saturday, May 18, 2024, 09:00 Hrs [IST] ...

Newly released clinical trial data on the GLP-1 agonist drug Wegovy found that weight loss was sustained for up to four years ...

NurPhoto/Getty Images Semaglutide is commonly used to treat type 2 diabetes and aid weight loss, but scientists are also ...

VK2735 is Viking's GLP-1 agonist, and it has achieved strong results in clinical trials. Participants in a phase 2 trial who ...

Mizuho analysts are betting the stock of the small biotech Terns Pharmaceuticals Inc. could rally sharply if the company’s ...

Viking Therapeutics (VKTX) stock falls after Roche (RHHBY) posted promising Phase 1 results for its experimental obesity ...